Correlation Between US Bancorp and Novo Nordisk

Can any of the company-specific risk be diversified away by investing in both US Bancorp and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Bancorp and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between US Bancorp PERP and Novo Nordisk AS, you can compare the effects of market volatilities on US Bancorp and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Bancorp with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Bancorp and Novo Nordisk.

Diversification Opportunities for US Bancorp and Novo Nordisk

0.5

Correlation Coefficient

US Bancorp  Novo Nordisk

Very weak diversification

The 3 months correlation between USB-PA and Novo is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding US Bancorp PERP and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and US Bancorp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Bancorp PERP are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of US Bancorp i.e., US Bancorp and Novo Nordisk go up and down completely randomly.

Pair Corralation between US Bancorp and Novo Nordisk

Assuming the 90 days trading horizon US Bancorp is expected to generate 5.32 times less return on investment than Novo Nordisk. But when comparing it to its historical volatility, US Bancorp PERP is 2.19 times less risky than Novo Nordisk. It trades about 0.01 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  12,880  in Novo Nordisk AS on February 1, 2024 and sell it today you would earn a total of  97.00  from holding Novo Nordisk AS or generate 0.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

US Bancorp PERP  vs.  Novo Nordisk AS

US Bancorp PERP

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in US Bancorp PERP are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental drivers, US Bancorp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Novo Nordisk AS

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Novo Nordisk AS are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Novo Nordisk reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with US Bancorp and Novo Nordisk

The main advantage of trading using opposite US Bancorp and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Bancorp position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.

The idea behind US Bancorp PERP and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.